Specify a stock or a cryptocurrency in the search bar to get a summary
Zoetis Inc
ZTSZoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey. Address: 10 Sylvan Way, Parsippany, NJ, United States, 07054
Analytics
WallStreet Target Price
219.34 USDP/E ratio
35.8627Dividend Yield
0.94 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ZTS
Dividend Analytics ZTS
Dividend growth over 5 years
198 %Continuous growth
10 yearsPayout Ratio 5 years average
25 %Dividend History ZTS
Stock Valuation ZTS
Financials ZTS
Results | 2019 | Dynamics |